Skip to content

Randomized, Prospective Evaluation of the Toad Brace in Plantar Ulcer Off-loading and Healing

Randomized, Prospective Evaluation of the Toad Brace in Plantar Ulcer Off-loading and Healing

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02052817
Enrollment
74
Registered
2014-02-03
Start date
2013-12-31
Completion date
Unknown
Last updated
2014-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot, Pedal Ulcers

Brief summary

The TOAD Medical Corporation Brace is a novel device that completely off-loads the foot and has been shown to heal ulcers at a rapid rate in preliminary experience in patients with plantar ulcers. This trial will attempt to show the efficacy of the Toad Brace and is based on the hypothesis that the Toad brace completely offloads the foot and hastens healing rates of diabetic ulcers. The trial will randomize 74 patients with diabetic pedal ulcers to the Toad Brace or conventional therapy. . Quantitative assessment of ulcer rate healing rates will be determined clinically and by blinded, computer-assisted planimetry of digital images over a 12 week period. The pressure on the plantar surface will be measured via a pressure sensor in a subset of patients. The trials will attempt to show markedly reduced pressure on the plantar surface and significantly higher ulcer healing rates with using the Toad Brace.

Interventions

DEVICEOptimal Medical Therapy Debridement + Toad Brace
OTHEROptimal Medical Therapy - Debridement

Sponsors

University Hospitals Cleveland Medical Center
CollaboratorOTHER
Toad Medical Corporation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men or women \>18 years old * One or more foot ulcers without clinical evidence of osteomyelitis * Diagnosis of Diabetes Mellitus\* * University of Texas Grade 1A, 1C, 2A, or 2C ulcer15 * ABI \>0.7 and Toe pressure \>30mmHg

Exclusion criteria

* Limited life-expectancy * Wounds on calf or shin that would be in contact with the TAG Brace * Gangrene, active infection * Osteomyelitis of the foot with the ulcer * Chronically bedridden/Non ambulatory * Unable to keep research appointments * Wide spread malignancy or systemically immunocompromising disease * Ipsilateral revascularization procedure within the last 30 days. * Unreliable, unwilling or unable to comprehend informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline measured wound areaEvery 3 weeks for a period of 12 weeksWe are taking repeated measures of wound area healing for pedal ulcers over a period of 12 weeks.

Countries

United States

Contacts

Primary ContactLori Hammer, RN
lori.hammer@uhhospitals.org216-983-4719

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026